Navigation Links
Study Author Urges Peers to Stop Using Pain Pumps in the Shoulder Joint as Seasonal Surge in Use Approaches
Date:10/11/2007

Beasley Allen investigating claims that pain pumps used in the shoulder

joint may cause life-long pain and suffering

MONTGOMERY, Ala., Oct. 11 /PRNewswire/ -- Dr. Charles Beck, a well-respected orthopedic surgeon this week issued a warning that a commonly used device designed to reduce pain after surgery is potentially dangerous when used in the shoulder joint space. The devices, manufactured by Stryker Corporation (NYSE: SYK), I-Flow Inc. (Nasdaq: IFLO) and others deliver high concentrations of pain medication directly to a surgical site, but according to a recently published article co-authored by Dr. Beck, they can cause permanent and debilitating damage to the shoulder.

"These devices have been used on thousands of patients nationwide, and based on our findings, hundreds appear to be at risk for this complication which results in severe pain, debilitating stiffness and eventual joint replacement surgery for many of those affected," says Dr. Charles Beck, an orthopedic surgeon and senior author of the study. "We sent the results of our study to the manufacturers more than two years ago, but their response has so far been minimal to non-existent. It is time to get the word out and stop these devices from ruining any more lives."

Manufacturers report that the number of orthopedic surgeries rise in the fourth quarter of each year tied to increased sports activity, particularly football and skiing. Patients also tend to defer elective surgeries until the fourth quarter after annual insurance deductibles are satisfied.

The article, published in the October 2007 issue of The American Journal of Sports Medicine (AJSM), demonstrates a strong association between the intra-articular (inside the joint space) use of high volume pain pumps following arthroscopic shoulder surgery and an otherwise unexplainable loss of hyaline cartilage in the shoulder joint. The complication, known as Postarthroscopic Glenohumeral Chondrolysis (PAGCL), is permanent and can lead to extreme pain and lifelong suffering in 63 percent of the patients that use them. The medical records of numerous other patients suggest the complications may occur following open surgery as well.

"We estimate that this could affect hundreds, if not thousands, of people all across the country," says attorney Ted Meadows of the Montgomery, Alabama.-based law firm Beasley, Allen, Crow, Methvin, Portis & Miles. Meadows is spokesperson for a group of firms that have already filed lawsuits against the companies that manufacture, market or distribute the pain pumps. The cases include U.S. District Court (Ore.) cases CV07-1318-HU, CV07-1309-AS and CV 07-1310 AA as well as Multnomah County Circuit Court (Portland, Ore.) case number 0703-02834. Their claims allege that the manufacturers failed to instruct or warn the U.S. medical community that the safety of using the pain pumps in the shoulder joint has not been established, and that the continuous injection of commonly used anesthetics by these devices may cause permanent injury.

To learn more about the devastating complications caused by use of a pain pump following shoulder surgery or how to file your own claim against the manufacturers, please call toll free (800) 898-2034 or visit http://www.painpump.net.

Contacts:

Ted G. Meadows

Beasley, Allen, Crow, Methvin, Portis & Miles

(800) 898-2034

ted.meadows@beasleyallen.com

Kevin Bush

Firmani + Associates Inc

(206) 443-9357

Kevin@firmani.com


'/>"/>
SOURCE Beasley, Allen, Crow, Methvin, Portis & Miles
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
(Date:12/8/2016)... Plainsboro, NJ (PRWEB) , ... December 08, 2016 , ... ... patients, cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts ... In making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Premier Fitness Camp ... FIT , the ultimate weight loss and wellness program, at their world headquarters of ... to provide immediate and long-term results to anyone seeking weight loss, personal development, a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) ... per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical Benchmarks ... (WCRI) . , According to the study, medical payments per claim in California decreased ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of ... report to their offering. ... The report also analyses the market by the following Technology Types: Label-Free ... the US, Canada , Japan , ... Latin America , and Rest of World. Annual ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a ... to address severe, rare diseases, today announced that senior management will ... Success Healthcare Conference at the InterContinental Barclay Hotel in ... 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma is engaged ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, Inc. ... (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to ... for the treatment of bacterial infections including those ... recognized as an attractive antibacterial target for more ... of suitable chemical starting points has hampered its ...
Breaking Medicine Technology: